How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

5,691 results for

Gestational Diabetes Management

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

61. Screening for gestational diabetes mellitus: are the criteria proposed by the International Association of the Diabetes and Pregnancy Study Groups cost-effective? Full Text available with Trip Pro

complications due to gestational diabetes were the key inputs for the model. Monetary benefit and utility valuations: The utility values for neonatal death, permanent brachial plexus injury, pre-term birth, and maternal diabetes were from published literature. Measure of benefit: Quality-adjusted life-years (QALYs) were the summary benefit measure and they were discounted at an annual rate of 3%. Cost data: The economic analysis included the costs of screening, management of diabetes, and pregnancy (...) Screening for gestational diabetes mellitus: are the criteria proposed by the International Association of the Diabetes and Pregnancy Study Groups cost-effective? Screening for gestational diabetes mellitus: are the criteria proposed by the International Association of the Diabetes and Pregnancy Study Groups cost-effective? Screening for gestational diabetes mellitus: are the criteria proposed by the International Association of the Diabetes and Pregnancy Study Groups cost-effective? Werner EF

2013 NHS Economic Evaluation Database.

62. Protease Inhibitor Exposure and Risk of Diabetes Mellitus, Gestational Diabetes and Pre-diabetes Among Treated HIV Seropositive Patients: A Systematic Review and Meta-Analysis

Protease Inhibitor Exposure and Risk of Diabetes Mellitus, Gestational Diabetes and Pre-diabetes Among Treated HIV Seropositive Patients: A Systematic Review and Meta-Analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability (...) will yield the same results as the fixed-effect model. For further details, see the and to pre-clinical meta-analysis. Example: Because of the exploratory nature of animal studies, a random effects model will be used to account for anticipated heterogeneity. ">Effect models Example: Heterogeneity will be assessed using the (residual) I2 and adjusted R2 statistics. ">Heterogeneity For further guidance please refer to the and to pre-clinical meta-analysis. Example: Whenever a control group serves more than

2020 PROSPERO

63. Systematic review with meta analysis: In women with gestational diabetes requiring drug treatment, glibenclamide may be inferior to insulin and metformin: metformin (plus insulin when required) performs better than insulin

Statistics from Altmetric.com Commentary on : Balsells M , Garia-Patterson A , Solà I , et al . Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis . Context Insulin therapy is recommended as a first-line approach after failure of diet therapy to manage gestational diabetes (GDM). 1 , 2 Not all women are suitable candidates or decline to use insulin to manage their blood glucose levels and alternative options are needed. Metformin (...) and glibenclamide are mentioned as alternatives to insulin for management of gestational diabetes mellitus (GDM) in several guidelines, 1 , 2 while National Institute for Health and Care Excellence guidelines recommend metformin as a first-line. 3 This systematic review and meta-analysis examines the short-term maternal and neonatal outcomes in women with GDM receiving glibenclamide, metformin or insulin in randomised controlled trials (RCTs). … Request Permissions If you wish to reuse any or all

2015 Evidence-Based Medicine

64. Gestational Diabetes Mellitus Screening & Diagnosis 2011

Gestational Diabetes Mellitus Screening & Diagnosis 2011 April 2014 Please be informed that the PSBC guideline you are looking for; Obstetric Guideline Gestational Diabetes Mellitus Screening and Diagnosis is under revision but still available by request. An updated clinical practice guideline is available through the: Canadian Diabetes Association 2013 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada – see Chapter 36 for Diabetes and Pregnancy at http (...) ://guidelines.diabetes.ca/Browse/Chapter36 The PSBC guideline for Diabetes Mellitus and Pregnancy Type 1 & 2 is also being revised. West Tower, 350-555 West 12th Avenue Vancouver, BC V5Z 3X7 Main Line: 604.877.2121 Fax: 604.872.1987 www.perinatalservicesbc.ca

2014 British Columbia Perinatal Health Program

65. Guideline Supplement: Gestational diabetes mellitus

be downloaded in Portable Document Format (PDF) from www.health.qld.gov.au/qcg 4.1 Guideline resources The following guideline components are provided on the website as separate resources: • Flowchart: Screening and diagnosis of GDM • Flowchart: Intrapartum management for GDM requiring Insulin and/or Metformin • Flowchart: Postpartum management for all women with GDM • Flowchart: Antenatal schedule of care • Education resource: Gestational diabetes mellitus • Knowledge assessment: Gestational diabetes (...) Guideline Supplement: Gestational diabetes mellitus Maternity and Neonatal C linical G uideline Department of Health Supplement: Gestational diabetes mellitus Queensland Clinical Guideline Supplement: Gestational diabetes mellitus Refer to online version, destroy printed copies after use Page 2 of 12 Table of Contents 1 Introduction 3 1.1 Funding 3 1.2 Conflict of interest 3 1.3 Guideline review 3 2 Methodology 4 2.1 Topic identification 4 2.2 Scope 4 2.3 Clinical questions 4 2.4 Exclusions 4

2015 Queensland Health

66. Gestational diabetes mellitus

• Maternal age = 40 years • Family history DM (1 st degree relative or sister with GDM) • Previous macrosomia (birth weight > 4500 g or > 90 th percentile • Previous perinatal loss • Polycystic Ovarian Syndrome • Medications (corticosteroids, antipsychotics) • Multiple pregnancy Queensland Clinical Guideline: Gestational diabetes mellitus Refer to online version, destroy printed copies after use Page 4 of 38 Flowchart: Intrapartum management for GDM requiring Insulin and/or Metformin Metformin • Cease (...) BMI: Body Mass Index DM: Diabetes Mellitus GDM: Gestational Diabetes Mellitus gest: gestational age HbA1c: Glycated haemoglobin OGTT: Oral glucose tolerance test =: greater than or equal to : greater than Queensland Clinical Guideline: Gestational diabetes mellitus. Guideline No: MN15.33-V1-R20 Assess all women for risk factors GDM care GDM diagnosis OGTT (preferred test for diagnosis) One or more of: • Fasting = 5.1 mmol/L • 1 hour = 10 mmol/L • 2 hour = 8.5 mmol/L HbA1c (if OGTT not suitable

2015 Queensland Health

67. Diabetes in Pregnancy and Gestational Diabetes Mellitus (GDM); Antidepressants in Pregnancy and Lactation

Diabetes in Pregnancy and Gestational Diabetes Mellitus (GDM); Antidepressants in Pregnancy and Lactation RxFiles Q&A Summary www.RxFiles.ca - April 2012 Lynette Kosar BSP, MSc Are Antidepressants Safe during Pregnancy & Breastfeeding? Up to ~25% of pregnant women will suffer from depression while pregnant. 1 The decision on how to treat depression and/or anxiety during & after pregnancy requires careful consideration of benefits and harms & collaborative discussions with the patient. SHOULD (...) Accessed February 21st, 2012. 5 Bonari L et al. Risks of untreated depression during pregnancy. Can Fam Physician. 2004 Jan;50:37-9. 6 National Institute for Health and Clinical Excellence. NICE Clinical Guideline 45 – Antenatal and postnatal mental health: Clinical management and service guidance. February 2007. http://www.nice.org.uk/nicemedia/live/11004/30433/30433.pdf Accessed February 21st, 2012. 7 Ryan D, Milis L, Misri N. Depression during pregnancy. Can Fam Physician. 2005 Aug;51:1087-93. 8

2012 RxFiles

68. Effect of Treatment of Mild Gestational Diabetes on Long-Term Maternal Outcomes. (Abstract)

Effect of Treatment of Mild Gestational Diabetes on Long-Term Maternal Outcomes.  The main purpose of this article is to evaluate whether identification and treatment of women with mild gestational diabetes mellitus (GDM) during pregnancy affects subsequent maternal body mass index (BMI), anthropometry, metabolic syndrome, and risk of diabetes. This is a follow-up study of women who participated in a randomized controlled treatment trial for mild GDM. Women were enrolled between 5 and 10 years (...) after their index pregnancy. Participants underwent blood pressure, height, weight, and anthropometric measurements by trained nursing personnel using a standardized approach. A nurse-assisted questionnaire regarding screening and treatment of diabetes or hypercholesterolemia, diet, and physical activity was completed. Laboratory evaluation included fasting serum glucose, fasting insulin, oral glucose tolerance test, and a lipid panel. Subsequent diabetes, metabolic syndrome, obesity, and adiposity

2019 American journal of perinatology Controlled trial quality: uncertain

69. Prevalence of gestational diabetes according to commonly used data sources: an observational study. Full Text available with Trip Pro

Prevalence of gestational diabetes according to commonly used data sources: an observational study. It is well recognized that prevalence of gestational diabetes mellitus (GDM) varies depending on the population studied and the diagnostic criteria used. The data source used also can lead to substantial differences in the reporting of GDM prevalence but is considered less frequently. Accurate estimation of GDM prevalence is important for service planning and evaluation, policy development (...) on diabetes status were collected from regional health boards and the Ministry of Health's National Minimum Dataset, plasma glucose results were collected from laboratories servicing the recruitment catchment area and coded according to the New Zealand Society for the Study of Diabetes diagnostic criteria, and self-reported diabetes status collected via interview administered questionnaires. Agreement between data sources was calculated using the proportion of agreement with 95% confidence intervals

2019 BMC Pregnancy and Childbirth

70. Pregnancy outcomes of early detected gestational diabetes: a retrospective comparison cohort study, Qatar. Full Text available with Trip Pro

Pregnancy outcomes of early detected gestational diabetes: a retrospective comparison cohort study, Qatar. To compare pregnancy outcomes in patients with early versus usual gestational diabetes mellitus (GDM).A retrospective cohort study.The Women's Hospital, Hamad Medical Corporation, Qatar.GDM women who attended and delivered in the Women's Hospital, between January and December 2016. GDM was diagnosed based on the 2013-WHO criteria. The study included 801 patients; of which, 273 E-GDM (...) and 528 U-GDM. Early GDM (E-GDM) and usual GDM (U-GDM) were defined as GDM detected before and after 24 weeks' gestation, respectively.Maternal and neonatal outcomes and the impact of timing of GDM-diagnosis on pregnancy outcomes.At conception, E-GDM women were older (mean age 33.5±5.4 vs 32.0±5.4 years, p<0.001) and had higher body mass index (33.0±6.3 vs 31.7±6.1 kg/m2, p=0.0059) compared with U-GDM. The mean fasting, and 1-hour blood glucose levels were significantly higher in E-GDM vs U-GDM

2019 BMJ open

71. Implementing a best-practice model of gestational diabetes mellitus care in dietetics: a qualitative study. Full Text available with Trip Pro

Implementing a best-practice model of gestational diabetes mellitus care in dietetics: a qualitative study. Translating research into clinical practice is challenging for health services. Emerging approaches in implementation science recognise the need for a theory-driven approach to identify and overcome barriers to guideline adherence. However, many clinicians do not have the capacity, confidence, or expertise to realise change in their local settings. Recently, two regional sites (...) participated in a facilitated implementation project of an evidence-based model of gestational diabetes mellitus (GDM) care in dietetics, supported by a team at a metropolitan centre. This study describes (i) stakeholder experiences', and (ii) learnings to inform implementation of the model of care (MOC) across Queensland.This qualitative descriptive study utilised semi-structured telephone interviews with staff involved in implementation of the MOC project at two regional sites. Eight participants were

2019 BMC health services research

72. Higher rates of large-for-gestational-age newborns mediated by excess maternal weight gain in pregnancies with Type 1 diabetes and use of continuous subcutaneous insulin infusion vs multiple dose insulin injection. (Abstract)

Higher rates of large-for-gestational-age newborns mediated by excess maternal weight gain in pregnancies with Type 1 diabetes and use of continuous subcutaneous insulin infusion vs multiple dose insulin injection. To compare glycaemic control, maternal and neonatal outcomes in pregnancies with Type 1 diabetes, managed either by continuous subcutaneous insulin infusion, multiple daily insulin injection or switch from multiple daily insulin injection (MDI) to continuous subcutaneous insulin (...) infusion (CSII) in early pregnancy.Data from 339 singleton pregnancies were retrospectively reviewed. HbA1c values were measured preconception and in each trimester. In a secondary analysis, use of CSII pre-pregnancy was compared with initiation of CSII during pregnancy.MDI was used in 140 pregnancies (41.3%) and CSII was used in 199 (58.7%), including 34 pregnancies (10.0%) during which the women switched to CSII. In pregnancies during which CSII was used duration of diabetes [median (interquartile

2019 Diabetic Medicine

73. The association of body composition with the risk of gestational diabetes mellitus in Chinese pregnant women: A case-control study. Full Text available with Trip Pro

of body composition may provide important guidance to identify gestational diabetes in pregnant women with low gestational diabetes risk. (...) The association of body composition with the risk of gestational diabetes mellitus in Chinese pregnant women: A case-control study. Studies have found that the measurement of body composition can be used to identify the gestational diabetes mellitus (GDM) risk in pregnant women. However, few studies focused on the relationship between body composition and GDM development in low GDM risk population. Thus, the objective of this study was to examine the association between body composition

2019 Medicine

74. Research Gaps in Gestational Diabetes Mellitus: Executive Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop. Full Text available with Trip Pro

Research Gaps in Gestational Diabetes Mellitus: Executive Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop. The National Institute of Diabetes and Digestive and Kidney Diseases convened a workshop on research gaps in gestational diabetes mellitus (GDM) with a focus on 1) early pregnancy diagnosis and treatment and 2) pharmacologic treatment strategies. This article summarizes the proceedings of the workshop. In early pregnancy, the appropriate diagnostic (...) criteria for the diagnosis of GDM remain poorly defined, and an effect of early diagnosis and treatment on the risk of adverse outcomes has not been demonstrated. Despite many small randomized controlled trials of glucose-lowering medication treatment in GDM, our understanding of medication management of GDM is incomplete as evidenced by discrepancies among professional society treatment guidelines. The comparative effectiveness of insulin, metformin, and glyburide remains uncertain, particularly

2018 Obstetrics and Gynecology

75. Reducing risk of type 2 diabetes after gestational diabetes: a qualitative study to explore the potential of technology in primary care. Full Text available with Trip Pro

Reducing risk of type 2 diabetes after gestational diabetes: a qualitative study to explore the potential of technology in primary care. Despite the seven-fold increased risk of type 2 diabetes mellitus (T2DM) among females previously diagnosed with gestational diabetes (GD), annual rates of follow-up in primary care are low. There is a need to consider how to reduce the incidence of progression to T2DM among this high-risk group.To examine the views of females diagnosed with GD to ascertain (...) by providing information, enabling flexible and personalised self-management, and facilitating social support.A more tailored approach for females previously diagnosed with GD may help reduce the risk of progression to T2DM. A need for future research to test the efficacy of using technology as an adjunct to current care was identified.© British Journal of General Practice 2018.

2018 British Journal of General Practice

76. Maternal, perinatal, and post-perinatal outcomes from Covid-19 in women with diabetes and gestational diabetes compared to normoglycaemic pregnancies: a systematic review and meta-analysis

Maternal, perinatal, and post-perinatal outcomes from Covid-19 in women with diabetes and gestational diabetes compared to normoglycaemic pregnancies: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility (...) or zero, the random-effects model will yield the same results as the fixed-effect model. For further details, see the and to pre-clinical meta-analysis. Example: Because of the exploratory nature of animal studies, a random effects model will be used to account for anticipated heterogeneity. ">Effect models Example: Heterogeneity will be assessed using the (residual) I2 and adjusted R2 statistics. ">Heterogeneity For further guidance please refer to the and to pre-clinical meta-analysis. Example

2020 PROSPERO

77. Multiple interventions for type 2 diabetes prevention in women with previous gestational diabetes: a systematic review and meta-analysis

Multiple interventions for type 2 diabetes prevention in women with previous gestational diabetes: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration (...) the same results as the fixed-effect model. For further details, see the and to pre-clinical meta-analysis. Example: Because of the exploratory nature of animal studies, a random effects model will be used to account for anticipated heterogeneity. ">Effect models Example: Heterogeneity will be assessed using the (residual) I2 and adjusted R2 statistics. ">Heterogeneity For further guidance please refer to the and to pre-clinical meta-analysis. Example: Whenever a control group serves more than one

2020 PROSPERO

78. Management of Preexisting Diabetes in Pregnancy: A Review. Full Text available with Trip Pro

Management of Preexisting Diabetes in Pregnancy: A Review. The presence of preexisting type 1 or type 2 diabetes in pregnancy increases the risk of adverse maternal and neonatal outcomes, such as preeclampsia, cesarean delivery, preterm delivery, macrosomia, and congenital defects. Approximately 0.9% of the 4 million births in the United States annually are complicated by preexisting diabetes.Women with diabetes have increased risk for adverse maternal and neonatal outcomes, and similar risks (...) are present with type 1 and type 2 diabetes. Both forms of diabetes require similar intensity of diabetes care. Preconception planning is very important to avoid unintended pregnancies and to minimize risk of congenital defects. Hemoglobin A1c goals are less than 6.5% at conception and less than 6.0% during pregnancy. It is also critical to screen for and manage comorbid illnesses, such as retinopathy and nephropathy. Medications known to be unsafe in pregnancy, such as angiotensin-converting enzyme

2019 JAMA

79. Pregnancy Health: Exercise Programs to Prevent Gestational Hypertension

excessive weight gain and prevent gestational diabetes ( ). This systematic review assessed the effectiveness of exercise programs in preventing gestational hypertensive disorders, defined as new onset high blood pressure during pregnancy. There are four different types of gestational hypertensive disorders: chronic hypertension, gestational hypertension, preeclampsia, and preeclampsia superimposed on chronic hypertension (Vest et al., 2014). This CPSTF finding is specific to one type—gestational (...) activity intervention assessed by pedometer with or without dietary intervention in obese pregnant women. Am J Obstet Gynecol . 2014;210:134.e1–9. Ruiz JR, Perales M, Pelaez M, Lopez C, Lucia A, Barakat R. Supervised exercise-based intervention to prevent gestational weight gain: a randomized controlled trial. Mayo Clin Proc . 2013;88:1388–97. Stafne SN, Salvesen K_A, Romundstad PR, Eggebø TM, Carlsen SM, Mørkved S. Regular exercise during pregnancy to prevent gestational diabetes: a randomized

2020 Community Preventive Services Task Force

80. Metformin vs exercise vs vitamin D vs probiotics for the prevention of gestational diabetes mellitus, in women at high risk of gestational diabetes mellitus: a network meta-analysis

Metformin vs exercise vs vitamin D vs probiotics for the prevention of gestational diabetes mellitus, in women at high risk of gestational diabetes mellitus: a network meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility (...) will yield the same results as the fixed-effect model. For further details, see the and to pre-clinical meta-analysis. Example: Because of the exploratory nature of animal studies, a random effects model will be used to account for anticipated heterogeneity. ">Effect models Example: Heterogeneity will be assessed using the (residual) I2 and adjusted R2 statistics. ">Heterogeneity For further guidance please refer to the and to pre-clinical meta-analysis. Example: Whenever a control group serves more than

2019 PROSPERO

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>